LLY

1,083.86

-1.74%↓

JNJ

223.31

-0.83%↓

ABBV

213.03

-2.26%↓

UNH

378.2

-0.12%↓

MRK

115.57

-2.55%↓

LLY

1,083.86

-1.74%↓

JNJ

223.31

-0.83%↓

ABBV

213.03

-2.26%↓

UNH

378.2

-0.12%↓

MRK

115.57

-2.55%↓

LLY

1,083.86

-1.74%↓

JNJ

223.31

-0.83%↓

ABBV

213.03

-2.26%↓

UNH

378.2

-0.12%↓

MRK

115.57

-2.55%↓

LLY

1,083.86

-1.74%↓

JNJ

223.31

-0.83%↓

ABBV

213.03

-2.26%↓

UNH

378.2

-0.12%↓

MRK

115.57

-2.55%↓

LLY

1,083.86

-1.74%↓

JNJ

223.31

-0.83%↓

ABBV

213.03

-2.26%↓

UNH

378.2

-0.12%↓

MRK

115.57

-2.55%↓

Kodu・Aktsiate loetelu・Embecta Corp

Embecta Corp

Avatud

SektorTervishoid

3.3 -1.79

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

3.27

Max

3.38

Põhinäitajad
By Trading Economics
Sissetulek	-48M -4.1M
Müük	-39M 222M
P/E Sektori keskmine	1.749 50.102
Aktsiakasum	0.27
Dividenditootlus	18.07
Kasumimarginaal	-1.849
Töötajad	1,850
EBITDA	-40M 56M

Soovitused
By TipRanks
Soovitused	Müü
12 kuu keskmine prognoos	+18.34% upside

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	18.07% 2.33%
Järgmine tulemuste avaldamine	7. aug 2026
Järgmine dividendimakse kuupäev	15. juuni 2026
Järgmine aktsia dividendi kuupäev (ex-date)	28. aug 2026

Turustatistika
By TradingEconomics
Turukapital	-352M 196M
Eelmine avamishind	5.09
Eelmine sulgemishind	3.3

Uudiste sentiment

By Acuity

50%

124 / 344 Pingereas Healthcare

Embecta Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

31. mai 2026, 23:44 UTC

Market Talk

Nikkei May Remain Rangebound Amid Middle East Uncertainty -- Market Talk

31. mai 2026, 23:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

31. mai 2026, 23:36 UTC

Market Talk

Oil Rises Amid Few Signs of Strait of Hormuz's Reopening -- Market Talk

31. mai 2026, 23:36 UTC

Market Talk

Watch for Data-Center Investment in Australia's 1Q GDP Print -- Market Talk

31. mai 2026, 22:54 UTC

Omandamised, ülevõtmised, äriostud

Berkshire Hathaway to Buy Homebuilder Taylor Morrison for $6.8 Billion -- WSJ

29. mai 2026, 23:08 UTC

Omandamised, ülevõtmised, äriostud

Family Offices Bypass Private Equity and Go Direct -- Barrons.com

29. mai 2026, 23:06 UTC

Omandamised, ülevõtmised, äriostud

After a Series of Sales, Hims Director Buys Company Shares -- Barrons.com

29. mai 2026, 20:53 UTC

Tulu

Oil Declines Lift Stocks to Fresh Records -- WSJ

29. mai 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

29. mai 2026, 20:33 UTC

Market Talk

Canada Meets Only One of Three Criteria To Declare Recession -- Market Talk

29. mai 2026, 20:11 UTC

Tulu

Okta Stock Soars. What's Stealing the Show From Earnings. -- Barrons.com

29. mai 2026, 19:47 UTC

Tulu

These Were the Best and Worst S&P 500 Stocks in May -- Barrons.com

29. mai 2026, 19:36 UTC

Market Talk

U.S. Natural Gas Futures End Month With Gains -- Market Talk

29. mai 2026, 19:34 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

29. mai 2026, 19:34 UTC

Market Talk

Over Half of Canadian Industries Growing, Undermining Recession Talk -- Market Talk

29. mai 2026, 19:22 UTC

Market Talk

Oil Falls as U.S., Iran Expected to Reach Agreement -- Market Talk

29. mai 2026, 19:05 UTC

Omandamised, ülevõtmised, äriostud

Universal Music Group Rejects $65 Billion Takeover Bid From Bill Ackman's Pershing Square -- Barrons.com

29. mai 2026, 18:19 UTC

Market Talk

Canada Technical Recession Chatter Rife But Per-Capita GDP Was Up -- Market Talk

29. mai 2026, 18:12 UTC

Omandamised, ülevõtmised, äriostud

Universal Music Group Rejects $65 Billion Buyout Offer From Bill Ackman -- WSJ

29. mai 2026, 18:11 UTC

Market Talk

Canada Households Reaching Limit at Keeping Spending in Positive Territory -- Market Talk

29. mai 2026, 18:10 UTC

Market Talk

As BTC Long-Term Holders Rise, Short-Term Holders Flee -- Market Talk

29. mai 2026, 17:55 UTC

Tulu

Okta Stock Soars. What's Stealing the Show From Earnings. -- Barrons.com

29. mai 2026, 17:55 UTC

Market Talk

NEAR Protocol Nearly Doubles in May -- Market Talk

29. mai 2026, 17:38 UTC

Market Talk

U.S. Oil Rig Count Rises for Fifth Straight Week -- Market Talk

29. mai 2026, 17:00 UTC

Tulu

Okta Stock Soars After Earnings. Results Aren't the Real Catalyst. -- Barrons.com

29. mai 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

29. mai 2026, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

29. mai 2026, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

29. mai 2026, 16:02 UTC

Market Talk

Gold Extend Gains as Investors Await U.S.-Iran Deal News -- Market Talk

29. mai 2026, 15:55 UTC

Market Talk

Global Equities Roundup: Market Talk

Võrdlus sarnastega

Hinnamuutus

Embecta Corp Prognoos

Hinnasiht

By TipRanks

18.34% tõus

12 kuu keskmine prognoos

Keskmine 4 USD 18.34%

Kõrge 5 USD

Madal 3 USD

Põhineb 3 Wall Streeti analüütiku instrumendi Embecta Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Müü

3 ratings

Osta

Hoia

Müü

Põhineb 3 analüütiku instrumendi Embecta Corp aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

124 / 344 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Embecta Corp

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.